Current: Global EditionSwitch to China Edition →
NASDAQ27,069+0.48%│S&P 5007,743+0.51%│BTC/USD$84,045-0.39%│CSI 3004,439-1.73%│DXY101.03+0.60%│VIX14.9-5.11%│GOLD$4,321-1.45%│NASDAQ27,069+0.48%│S&P 5007,743+0.51%│BTC/USD$84,045-0.39%│CSI 3004,439-1.73%│DXY101.03+0.60%│VIX14.9-5.11%│GOLD$4,321-1.45%│
M
Meridian

sectors

Healthcare

Daily curated global finance headlines in this column. 500 articles.

Free global finance digest · Premium delivery for the best picks

Daily overseas finance news in-app; members get curated thesis, variables, and trade logic via email/SMS before the open.

MembershipNotifications
16 hr ago
LGND

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation. Market participants are assessing the implications for related sectors and asset pr…

Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.

Read full article →
1 d ago
QTEX

Inspira Technologies Oxy GAAP EPS of -$0.14 misses by $0.26, revenue of $1.55M

Inspira Technologies Oxy GAAP EPS of -$0.14 misses by $0.26, revenue of $1.55M. Market participants are assessing the implications for related sectors and asset…

Meridian Intelligence View: Meridian Intelligence view: The AI boom is entrepreneurial action chasing marginal returns from new tech. Capital inflows inflate valuations; only services consumers willingly pay for represent genuine productivity progress.

Read full article →
1 d ago
LGND

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies. Market participants are assessing the implications for related sectors and asset price…

Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.

Read full article →

Disclaimer

Auto-fetched and translated global finance news for research only. Not investment advice.